Transcriptional regulation of human α1(I) procollagen gene in dermal fibroblasts

AIM: To clarify the fractional activity of promoters from human α1(I) procollagen gene, the interaction between ciselements and consensus DNA-binding proteins responsible for high promoter activity, and the potential application of promoter competitors as well as cytokines for antifibrogenesis.METHODS: Sequence between 2 483 bp upstream of the start of transcription and 42 bp downstream of this site was investigated with serial 5'-deletion. The 5'-deleted promoters recombined with chloramphenicol acetyltransferase (CAT) as reporter gene were transiently transfected to human dermal fibroblasts. Electrophoretic mobility shift assay was performed to show the DNA-protein binding capacity of the promoter sequence. Cytokines including tumor necrosis factor α(TNFα) and interferons (INFs) were added to the culture medium of transiently transfected fibroblasts.Competitor DNA for the binding sites of Sp-1, Ap-1 and NF-1 was individually cotransfected transiently in order to block the promoter-driven CAT expression.RESULTS: Sequences of -2 483 to +42 bp and -268 to +42 bp of human α1(I) procollagen gene had high activity as promoters. Binding sites for Ap-1 and Sp-1 were among the cis-regulatory elements recognizing consensus transcription factors responsible for basal promoter activity of sequence -268 to +42 bp. TNFα, IFNα, IFNβ showed inhibitory effects on sequence -2 483 to +42 bp as promoter with activities 43%, 62% and 60% of control respectively. Transfection of the promoter competitors could reverse the promoter activity of -268 to +42 bp 40-60%.CONCLUSION: Sequences of -2 483 to +42 bp recombined with reporter gene provide an ideal construction for transcriptional study of α1(I) procollagen gene. The anticollagen capacity of TNFα and IFNs is associated with their transcriptional regulation. Ap-1 and Sp-1 mediate the basal transcriptional activation of human α1(I) procollagen gene in dermal fibroblasts. Competitors for highly active promoters might be a novel potential candidate in fibrotic blockade.

AIM: To clarify the fractional activity of promoters from human α1(I) procollagen gene,the interaction between cis- elements and consensus DNA-binding proteins responsible for high promoter activity,and the potential application of promoter competitors as well as cytokines for antifibrogenesis. METHODS: Sequence between 2 483 bp upstream of the start of transcription and 42 bp downstream of this site was investigated with serial 5'-deletion.The 5'-deleted promoters recombined with chloramphenicol acetyltransferase (CAT) as reporter gene were transiently transfected to human dermal fibroblasts.Electrophoretic mobility shift assay was performed to show the DNA-protein binding capacity of the promoter sequence.Cytokines including tumor necrosis factor α (TNFα) and interferons (INFs) were added to the culture medium of transiently transfected fibroblasts. Competitor DNA for the binding sites of Sp-1,Ap-1 and NF- 1 was individually cotransfected transiently in order to block the promoter-driven CAT expression. RESULTS: Sequences of -2 483 to +42 bp and -268 to +42 bp of human α(I) procollagen gene had high activity as promoters.Binding sites for Ap-1 and Sp-1 were among the cis-regulatory elements recognizing consensus transcription factors responsible for basal promoter activity of sequence -268 to +42 bp.TNFα,IFNα,IFNβ showed inhibitory effects on sequence -2 483 to +42 bp as promoter with activities 43%,62% and 60% of control respectively.Transfection of the promoter competitors could reverse the promoter activity of -268 to +42 bp 40-60%. CONCLUSION: Sequences of -2 483 to +42 bp recombined with reporter gene provide an ideal construction for transcriptional study of α1(I) procollagen gene.The anti- collagen capacity of TNFα and IFNs is associated with their transcriptional regulation.Ap-1 and Sp-1 mediate the basal transcriptional activation of human α1(I) procollagen gene in dermal fibroblasts.Competitors for highly active promoters might be a novel potential candidate in fibrotic blockade.